• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe newsletter
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

doctor's note

AI-generated Doctor’s Letters show promise in German healthcare study

AI, doctor's note, Research, 7 October 2024/in E-News, MedTech /by panglobal

Researchers at the Medical Center – University of Freiburg demonstrate that artificial intelligence can effectively produce medical documentation, potentially reducing physicians’ administrative burden.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/10/doc_note.jpg 320 480 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-10-07 08:00:522024-10-03 11:43:20AI-generated Doctor’s Letters show promise in German healthcare study
Researchers have mapped nearly 140,000 neurons in the fruit-fly brain.

Unveiling the neural labyrinth: Fruit fly brain map sets new benchmark in neuroscience

neurology, Research, 4 October 2024/in E-News, Neurology, Research /by panglobal

Researchers unveil the most comprehensive neural map of an adult animal brain to date, offering unprecedented insights into brain circuitry and function.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/10/fruit_fly_brain_map.jpg 1400 2472 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-10-04 08:00:042024-10-03 11:36:39Unveiling the neural labyrinth: Fruit fly brain map sets new benchmark in neuroscience
Johan Frostegård

New cardiovascular risk marker identified in older women

biomarker, heart disease, Karolinska Institutet, women, 3 October 2024/in Cardiology, E-News, Women's Health /by panglobal

A study from Karolinska Institutet reveals that low levels of anti-phosphorylcholine antibodies may indicate increased risk of heart disease in older women, potentially paving the way for improved risk assessment and preventive strategies.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/10/Johan-Frostegard.jpg 522 359 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-10-03 08:00:092024-10-02 11:02:35New cardiovascular risk marker identified in older women
MiCCrobioTAckle

New European research network to explore gut microbiome’s role in tumour cachexia

Europe, microbiome, tumour cachexia, 2 October 2024/in E-News, Oncology /by panglobal

The EU-funded ‘MiCCrobioTAckle’ project brings together 24 partners from 12 countries to investigate the complex interplay between intestinal microbiota and cancer-associated muscle wasting.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/10/Logo_MiCCrobioTAckle.png 910 1229 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-10-02 10:37:092024-10-02 10:37:09New European research network to explore gut microbiome’s role in tumour cachexia
Critical Care Nurse

New blueprint calls for radical overhaul of acute and critical care nursing metrics

critical care, metrics, nursing, patient outcomes, 30 September 2024/in Critical Care, E-News, Nursing /by panglobal

Researchers propose a comprehensive framework to better measure and recognise the full scope of nurses’ contributions to patient care and outcomes.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/09/critical_care_nurse.jpg 679 1018 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-09-30 08:00:462024-09-27 08:13:45New blueprint calls for radical overhaul of acute and critical care nursing metrics
surgeons at work

New guideline for cardiovascular management in noncardiac surgery released

cardiovascular risk, Circulation, guideline, JACC, Surgery, 27 September 2024/in Cardiology, E-News, Surgery /by panglobal

The American Heart Association and American College of Cardiology have jointly published an updated guideline for managing cardiovascular risks in patients undergoing noncardiac surgery, reflecting a decade of new evidence since the last update in 2014.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/09/surgeons_at_work.jpg 679 1018 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-09-27 08:06:092024-09-27 08:06:09New guideline for cardiovascular management in noncardiac surgery released
80% of pregnant women affected by iron deficiency in third trimester

Study reveals 80% of pregnant women affected by iron deficiency in third trimester

anaemia, foetal iron accretion, iron deficiency, pregnancy, 26 September 2024/in E-News, Editors' Picks, Obs Gyn, Research, Women's Health /by panglobal

Researchers find over 80% of women are iron deficient by their third trimester despite the absence of anaemia in early pregnancy, even in high-resource settings, highlighting the need for improved screening and treatment protocols.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/09/pregnant_woman.jpg 745 926 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-09-26 09:35:182024-09-25 13:19:08Study reveals 80% of pregnant women affected by iron deficiency in third trimester
donanemab Kinsula

FDA under fire: Controversial Alzheimer’s drug donanemab approved amid excess death concerns and conflicts of interest

Alzheimer’s, donanemab, Eli Lilly, FDA, The BMJ, 26 September 2024/in dementia, E-News, Editors' Picks, Featured Articles, Patient Safety, pharmacology, Regulation /by panglobal

A new investigation of FDA-approved Alzheimer’s drug donanemab highlights concerns about excess deaths, missing safety data, and financial conflicts of interest among FDA advisory panel members who recommended approval.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/09/donanemab_kinsula_web.jpg 800 1200 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-09-26 02:00:412024-09-25 13:29:05FDA under fire: Controversial Alzheimer’s drug donanemab approved amid excess death concerns and conflicts of interest

Single-dose gene therapy dramatically reduces bleeds in haemophilia B patients

FDA, gene therapy, haemophilia B, Research, 26 September 2024/in Congenital Diseases, E-News /by panglobal

A single-dose gene therapy has demonstrated significant reduction in bleeding episodes for adults with haemophilia B, potentially offering a long-term solution to this genetic disorder.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/09/blood25.jpg 720 960 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-09-26 01:00:122024-09-25 13:03:21Single-dose gene therapy dramatically reduces bleeds in haemophilia B patients

Subtle word choices can significantly impact patient-clinician communication, study finds

communication, consultation, diagnosis, language, patient satisfaction, 24 September 2024/in E-News, Editors' Picks /by panglobal

New research highlights how small changes in clinicians’ language can affect patient outcomes, from diagnostic accuracy to treatment adherence.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/09/doctor-patient.jpg 876 1314 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-09-24 08:00:112024-09-25 13:39:32Subtle word choices can significantly impact patient-clinician communication, study finds
Page 12 of 231«‹1011121314›»

Latest issue of International Hospital

April 2024

1 July 2025

BMJ investigation reveals AstraZeneca’s billion-dollar heart drug built on flawed data

27 June 2025

Scientists launch world first project to create synthetic human genome with £10mn Wellcome funding

27 June 2025

GE HealthCare advances precision imaging with MIM Encore platform

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription